Xalud Therapeutics Stock

xaludthera.comBioTechFounded: 2009Funding to Date: $69.89MM

Xalud Therapeutics specializes in treatments for neuro-inflammatory diseases.

Enterprise Value (based on primary financings)

Register for Details

For more details on financing and valuation for Xalud Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Xalud Therapeutics in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM